At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

NCT ID: NCT04393961

Last Updated: 2020-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-05

Study Completion Date

2020-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID19 COVID-19 Coronavirus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

This study will include four arms. The experiences across all 4 arms will be exactly the same. Each arm has a slightly different experience with COVID-19.
Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

This is a device feasibility trial. There is no blinding or masking.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Past Positive COVID-19 confirmed

Invited participants who Radish Health has completed a positive COVID-19 test who have recovered from all symptoms for more than 14 days.

Group Type OTHER

Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Intervention Type DEVICE

Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.

The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.

We chose the Precision Bio test for 4 reasons

1. It is available as a single use test kit in one sealed unit.
2. It's a rapid test, with results available in 10 minutes.
3. It has clear and easy to read instructions already included
4. It has one of the lowest false positive rates of known tests at the moment

Physician Diagnosed: Not Tested

Individuals who self report that a medical professional has told them they likely have COVID-19 (and have since recovered), but did not get a confirmatory test.

Group Type OTHER

Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Intervention Type DEVICE

Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.

The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.

We chose the Precision Bio test for 4 reasons

1. It is available as a single use test kit in one sealed unit.
2. It's a rapid test, with results available in 10 minutes.
3. It has clear and easy to read instructions already included
4. It has one of the lowest false positive rates of known tests at the moment

Self-Diagnosed Not Tested

Participant suspects they contracted (and have since recovered) from COVID-19, but they do not have a medical diagnosis or confirmatory test.

Group Type OTHER

Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Intervention Type DEVICE

Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.

The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.

We chose the Precision Bio test for 4 reasons

1. It is available as a single use test kit in one sealed unit.
2. It's a rapid test, with results available in 10 minutes.
3. It has clear and easy to read instructions already included
4. It has one of the lowest false positive rates of known tests at the moment

Likely Exposed, No Symptoms. Not Tested

Participant suspects that they've been exposed to COVID-19, but have not shown symptoms and wonder if they have antibodies so they may return to some normalcy.

Group Type OTHER

Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Intervention Type DEVICE

Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.

The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.

We chose the Precision Bio test for 4 reasons

1. It is available as a single use test kit in one sealed unit.
2. It's a rapid test, with results available in 10 minutes.
3. It has clear and easy to read instructions already included
4. It has one of the lowest false positive rates of known tests at the moment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.

The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.

We chose the Precision Bio test for 4 reasons

1. It is available as a single use test kit in one sealed unit.
2. It's a rapid test, with results available in 10 minutes.
3. It has clear and easy to read instructions already included
4. It has one of the lowest false positive rates of known tests at the moment

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Reside and Currently in New York City
* Does not have a blood clotting disease
* Is not abnormally queasy about taking a blood sample
* Not on any blood thinning medications
* Able to consent
* Willingness to take a blood sample
* Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Radish Health

UNKNOWN

Sponsor Role collaborator

Sanesco

UNKNOWN

Sponsor Role collaborator

ProofPilot

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ProofPilot Online App (https://p.proofpilot.com)

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Viral Patel, MD

Role: CONTACT

(833)-4-RADISH

Matthew Amsden

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Matthew Amsden

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2458

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Immunity Assessment
NCT05080231 COMPLETED